Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines

This study has been terminated.
(Terminated: recruiting or enrolling participants has halted prematurely)
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT01244711
First received: November 18, 2010
Last updated: December 19, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)